非药物干预减少创伤后应激障碍、抑郁或焦虑症状:系统综述与Meta分析
该系统综述与Meta分析检索了PubMed、Embase、Web of Science、PsychINFO、Cochrane Central Register of Controlled Trials和Google Scholar自建库至2023年12月28日的文献,纳入18岁及以上、遭受躯体创伤后1年内评估PTSD、抑郁或焦虑症状的英文随机对照试验。共识别3001篇文章进行标题和摘要审查。非药物干预总体上显著预防或治疗PTSD(合并SMD -0.71;95%CI -1.06至-0.36)、抑郁(合并SMD -0.42;95%CI -0.68至-0.17)和焦虑(合并SMD -0.69;95%CI -1.01至-0.37)。认知行为疗法与PTSD(合并SMD -1.10;95%CI -1.54至-0.66)、抑郁(合并SMD -0.87;95%CI -1.22至-0.52)和焦虑症状减轻相关;非认知行为疗法显著减轻焦虑(合并SMD -0.40;95%CI -0.74至-0.07)。协作医疗、非认知行为疗法和数字治疗对PTSD和抑郁未达到显著性。作者认为,认知行为疗法对PTSD、抑郁和焦虑有效,非认知行为疗法对焦虑有效。
要点
- 非药物干预总体上显著改善躯体创伤后PTSD(合并SMD -0.71;95%CI -1.06至-0.36)、抑郁(合并SMD -0.42;95%CI -0.68至-0.17)和焦虑(合并SMD -0.69;95%CI -1.01至-0.37)。
- 认知行为疗法与PTSD(合并SMD -1.10;95%CI -1.54至-0.66)、抑郁(合并SMD -0.87;95%CI -1.22至-0.52)和焦虑症状减轻相关。
- 非认知行为疗法显著减轻焦虑(合并SMD -0.40;95%CI -0.74至-0.07),但对PTSD和抑郁未达到显著性。
- 协作医疗和数字治疗对PTSD和抑郁未达到显著性。
- 证据等级为Level III(系统综述与Meta分析)。
适用人群与场景
- 18岁及以上、遭受躯体创伤后1年内评估PTSD、抑郁或焦虑症状的平民患者。
研究设计与关键结果
- 研究类型为随机对照试验的系统综述与Meta分析,检索PubMed、Embase、Web of Science、PsychINFO、Cochrane Central Register of Controlled Trials和Google Scholar自建库至2023年12月28日,纳入英文随机对照试验,对象为18岁及以上、遭受躯体创伤后1年内评估PTSD、抑郁或焦虑症状的患者,共识别3001篇文章进行标题和摘要审查。
- 非药物干预总体上显著预防或治疗PTSD(合并SMD -0.71;95%CI -1.06至-0.36)、抑郁(合并SMD -0.42;95%CI -0.68至-0.17)和焦虑(合并SMD -0.69;95%CI -1.01至-0.37)。
- 认知行为疗法与PTSD(合并SMD -1.10;95%CI -1.54至-0.66)、抑郁(合并SMD -0.87;95%CI -1.22至-0.52)和焦虑症状减轻相关。
- 非认知行为疗法显著减轻焦虑(合并SMD -0.40;95%CI -0.74至-0.07)。
- 协作医疗、非认知行为疗法和数字治疗对PTSD和抑郁未达到显著性。
证据类型、等级与局限
- 证据类型:随机对照试验的系统综述与Meta分析;证据等级:Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,认知行为疗法对PTSD、抑郁和焦虑有效,非认知行为疗法对焦虑有效。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Recent novel digital interventions may be transformative in overcoming persistent barriers to access in-person psychological therapies.
OBJECTIVE: This study aimed to synthesize evidence from randomized controlled trials (RCTs) of nonpharmacological interventions that prevents or treats anxiety, depression, or posttraumatic stress disorder (PTSD) among civilians recovering from physical traumatic injury.
METHODS: We searched PubMed, Embase, Web of Science, PsychINFO, Cochrane Central Register of Controlled Trials, and Google Scholar for articles since inception to December 28, 2023. We performed English-language RCTs of patients 18 years or older who sustained a physical injury and were assessed for symptoms of PTSD, depression, or anxiety within 1 year of injury. Dual reviewers performed screening for advancement to full-text review, data extraction, and final eligibility for systematic review and meta-analysis, and conflicts were resolved by the senior author. Meta-analysis used random effects. The primary outcome was standardized mean difference (SMD) between intervention and comparator groups.
RESULTS: We identified 3,001 articles for title and abstract review. Overall, nonpharmacological interventions significantly prevented or treated PTSD (pooled SMD, -0.71; 95% confidence interval [CI], -1.06 to -0.36), depression (pooled SMD, -0.42; 95% CI, -0.68 to -0.17), and anxiety (pooled SMD, -0.69; 95% CI, -1.01 to -0.37). Cognitive behavioral therapy (CBT) was associated with decreased symptoms of PTSD (pooled SMD, -1.10; 95% CI, -1.54 to -0.66), depression (pooled SMD, -0.87; 95% CI, -1.22 to -0.52), and anxiety. Non-CBT significantly reduced anxiety (pooled SMD, -0.40; 95% CI, -0.74 to -0.07). Collaborative care, non-CBT, and digital treatments failed to reach significance for PTSD and depression.
CONCLUSION: Our systematic review and meta-analysis of RCTs suggest efficacy of CBT for PTSD, depression, and anxiety and non-CBT for anxiety, after physical trauma.
LEVEL OF EVIDENCE: Systematic Review and Meta-analysis; Level III.
参考来源
- Solarczyk J, Ciminero M, Sprague S, et al. Nonpharmacological interventions to reduce posttraumatic stress disorder, depression, or anxiety symptoms after trauma: A systematic review and meta-analysis. J Trauma Acute Care Surg. 2025. PMID: 40434848. doi:10.1097/TA.0000000000004673
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。